FDA Drug Application (021039) for AGENERASE by GLAXOSMITHKLINE

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Application Number021039
Product Number001
FormSOLUTION;ORAL
Dosage15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameAGENERASE
Active IngredientAMPRENAVIR



Back to FDA Applications sponsored by GLAXOSMITHKLINE